Alzchem Group AG (XTER:ACT) Growth Rank: 9 (As of Jul. 19, 2026) — 13% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:ACT Alzchem Group AG XTER:ACT
60 GF Score
Price €174.20
GF Value €59.46
! 4 Warning Signs
View Full Analysis

What is Alzchem Group AG Growth Rank?

Alzchem Group AG XTER:ACT +0.29% 60 Growth Rank is 9 as of Jul. 19, 2026, which is 13% above its 10-year median of 8.00. GuruFocus rates XTER:ACT with a GF Score™ of 60/100 and a GF Value™ of €59.46. The stock has 4 warning signs investors should review.

Alzchem Group AG has the Growth Rank of 9.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Alzchem Group AG Growth Rank Related Terms

XTER:ACT vs LIN, SHW, ECL: Growth Rank Comparison

For the Specialty Chemicals subindustry, Alzchem Group AG's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alzchem Group AG Growth Rank vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Alzchem Group AG's Growth Rank distribution charts can be found below:

* The bar in red indicates where Alzchem Group AG's Growth Rank falls into.


XTER:ACT
60GF Score
Alzchem Group AG XTER:ACT
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 9 mean?
Alzchem Group AG (XTER:ACT) has a Growth Rank of 9 as of Jul. 19, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Alzchem Group AG and its competitors. This is 13% above median its historical median of 8.00. Over the past decade, Alzchem Group AG's Growth Rank has ranged from 3.00 to 9.00.
Is Alzchem Group AG's Growth Rank too high?
Alzchem Group AG's current Growth Rank of 9 is 13% above median its 10-year median of 8.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 9.00. Overall, Alzchem Group AG has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's Growth Rank compare to LIN and SHW?
Alzchem Group AG's Growth Rank of 9 can be compared against companies in the Chemicals industry. Historically, Alzchem Group AG's own Growth Rank has ranged from 3.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Chemicals company?
A good Growth Rank depends on the Chemicals industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Alzchem Group AG and its competitors. Alzchem Group AG's current Growth Rank is 9, which is 13% above median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Alzchem Group AG (XTER:ACT) has a current Growth Rank of 9. The stock's GF Value™ is €59.46, compared to a current price of €174.20 — trading 193% above its estimated fair value. The current Growth Rank is 9, which is 13% above median its 10-year median of 8.00. Alzchem Group AG's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Alzchem Group AG (XTER:ACT), the current Growth Rank is 9 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alzchem Group AG (XTER:ACT) Overvalued in 2026?

Based on GuruFocus' analysis, Alzchem Group AG stock appears to be overvalued. The current stock price of €174.20 is trading 193% above its estimated GF Value™ of €59.46.

Key valuation signals for XTER:ACT:

  • Growth Rank: 9 (13% above median its 10-year median of 8.00)
  • GF Value™: €59.46 vs. price of €174.20 (193% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the XTER:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alzchem Group AG Business Description

Address Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
60GF Score

Get the complete analysis for XTER:ACT

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€174.20
Price
€59.46
GF Value